An evidence-based approach to the post-marketing withdrawal of medicinal products because of adverse reactions

類似資料

• Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
  著者:: Stefania Chiappini, 等
  出版事項: (2020-02-01)
• Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
  著者:: Onakpoya, I, 等
  出版事項: (2016)
• The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
  著者:: Łukasz Dobrek
  出版事項: (2022-08-01)
• Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
  著者:: Onakpoya, IJ, 等
  出版事項: (2016)
• Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
  著者:: Igho J. Onakpoya, 等
  出版事項: (2019-03-01)